PXYLP1
Basic information
Region (hg38): 3:141228726-141367753
Previous symbols: [ "ACPL2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PXYLP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 26 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 26 | 1 | 0 |
Variants in PXYLP1
This is a list of pathogenic ClinVar variants found in the PXYLP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-141260219-C-T | not specified | Uncertain significance (Dec 07, 2021) | ||
3-141278420-C-T | not specified | Uncertain significance (Aug 02, 2023) | ||
3-141278425-C-G | not specified | Uncertain significance (Jun 07, 2024) | ||
3-141279425-C-T | not specified | Uncertain significance (Feb 02, 2024) | ||
3-141279450-A-G | not specified | Uncertain significance (Aug 15, 2023) | ||
3-141279459-C-T | not specified | Uncertain significance (Jul 21, 2021) | ||
3-141279462-A-G | not specified | Uncertain significance (Feb 06, 2023) | ||
3-141287319-C-T | not specified | Uncertain significance (Jun 11, 2024) | ||
3-141287381-G-A | not specified | Uncertain significance (Jan 04, 2022) | ||
3-141292303-A-T | not specified | Uncertain significance (Dec 20, 2023) | ||
3-141292351-G-A | not specified | Likely benign (Apr 08, 2022) | ||
3-141292462-C-T | not specified | Uncertain significance (Dec 05, 2022) | ||
3-141292475-C-T | not specified | Uncertain significance (Apr 12, 2023) | ||
3-141292478-T-C | not specified | Uncertain significance (Mar 07, 2024) | ||
3-141292489-G-A | not specified | Uncertain significance (Dec 03, 2021) | ||
3-141292541-G-A | not specified | Uncertain significance (Feb 16, 2023) | ||
3-141292556-G-A | not specified | Uncertain significance (Jan 17, 2023) | ||
3-141292615-C-T | not specified | Uncertain significance (Jan 05, 2022) | ||
3-141292654-A-G | not specified | Uncertain significance (Jun 06, 2023) | ||
3-141292912-C-A | not specified | Uncertain significance (Sep 13, 2023) | ||
3-141293012-A-G | not specified | Uncertain significance (Apr 24, 2024) | ||
3-141293020-C-T | not specified | Uncertain significance (Mar 28, 2024) | ||
3-141293041-G-A | not specified | Uncertain significance (May 14, 2024) | ||
3-141293056-A-G | not specified | Uncertain significance (Dec 22, 2023) | ||
3-141293077-C-T | not specified | Uncertain significance (Nov 03, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PXYLP1 | protein_coding | protein_coding | ENST00000286353 | 5 | 66181 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00309 | 0.987 | 125729 | 0 | 19 | 125748 | 0.0000756 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.720 | 253 | 287 | 0.880 | 0.0000168 | 3175 |
Missense in Polyphen | 81 | 100.05 | 0.80963 | 1108 | ||
Synonymous | -0.260 | 117 | 113 | 1.03 | 0.00000666 | 938 |
Loss of Function | 2.25 | 7 | 17.0 | 0.412 | 8.26e-7 | 213 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000907 | 0.0000905 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000968 | 0.0000967 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000163 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Responsible for the 2-O-dephosphorylation of xylose in the glycosaminoglycan-protein linkage region of proteoglycans thereby regulating the amount of mature glycosaminoglycan (GAG) chains. Sulfated glycosaminoglycans (GAGs), including heparan sulfate and chondroitin sulfate, are synthesized on the so-called common GAG-protein linkage region (GlcUAbeta1-3Galbeta1-3Galbeta1- 4Xylbeta1-O-Ser) of core proteins, which is formed by the stepwise addition of monosaccharide residues by the respective specific glycosyltransferases. Xylose 2-O-dephosphorylation during completion of linkage region formation is a prerequisite for the initiation and efficient elongation of the repeating disaccharide region of GAG chains. {ECO:0000269|PubMed:24425863}.;
Intolerance Scores
- loftool
- rvis_EVS
- -0.38
- rvis_percentile_EVS
- 28.01
Haploinsufficiency Scores
- pHI
- 0.182
- hipred
- Y
- hipred_score
- 0.595
- ghis
- 0.466
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Pxylp1
- Phenotype
- hematopoietic system phenotype; skeleton phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- glycosaminoglycan biosynthetic process;positive regulation of heparan sulfate proteoglycan biosynthetic process;dephosphorylation;chondroitin sulfate proteoglycan biosynthetic process
- Cellular component
- Golgi membrane;Golgi apparatus;integral component of membrane
- Molecular function
- protein binding;phosphatase activity